Yuvidoc-MR Tablet is a combination medication containing Chlorzoxazone 250mg, Diclofenac 50mg, and Paracetamol 325mg, formulated to provide effective relief from musculoskeletal pain and inflammation. Chlorzoxazone acts as a centrally acting muscle relaxant that helps alleviate muscle spasms and stiffness by depressing nerve impulses in the spinal cord and subcortical areas of the brain. Diclofenac, a nonsteroidal anti-inflammatory drug (NSAID), exerts potent anti-inflammatory, analgesic, and antipyretic effects by inhibiting cyclooxygenase enzymes, thereby reducing the synthesis of prostaglandins responsible for pain and inflammation. Paracetamol contributes additional analgesic and antipyretic benefits by acting centrally to inhibit prostaglandin synthesis and modulate pain perception. The synergistic combination of these three agents makes Yuvidoc-MR Tablet suitable for the management of acute musculoskeletal conditions such as strains, sprains, back pain, and other soft tissue injuries. It is recommended to be used under medical supervision, considering potential contraindications such as hypersensitivity to any component, gastrointestinal ulcers, liver or kidney impairment, and cardiovascular risks associated with NSAIDs. Patients should adhere to prescribed dosages and report any adverse reactions promptly to their healthcare provider.